TDGF1 Antikörper (AA 35-188)
Kurzübersicht für TDGF1 Antikörper (AA 35-188) (ABIN7171776)
Target
Alle TDGF1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 35-188
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human Teratocarcinoma-derived growth factor 1 protein (35-188AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
-
Andere Bezeichnung
- TDGF1
-
Hintergrund
-
Background: Could play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm.
Aliases: CR antibody, CRGF antibody, Cripto 1 antibody, Cripto 1 growth factor antibody, cripto antibody, Cripto-1 growth factor antibody, Cripto1 growth factor antibody, Epidermal growth factor like cripto protein CR1 antibody, Epidermal growth factor-like cripto protein CR1 antibody, TDGF 1 antibody, TDGF1 antibody, TDGF1_HUMAN antibody, Teratocarcinoma derived growth factor 1 antibody, Teratocarcinoma-derived growth factor 1 antibody
-
UniProt
- P13385
-
Pathways
- EGFR Signaling Pathway
Target
-